Lipid Disorders

How to Cite This Chapter: Attalla M, Curnew G, Pare G, Cybulska B, Kłosiewicz-Latoszek L, Szostak W. Lipid Disorders. McMaster Textbook of Internal Medicine. Kraków: Medycyna Praktyczna. Accessed November 30, 2021.
Last Updated: August 22, 2020
Last Reviewed: August 22, 2020
Chapter Information


Dyslipidemias are conditions in which plasma concentrations of lipids, lipoproteins, or triglycerides are considered elevated based on the patient’s total cardiovascular disease risk.

Total cholesterol, high-density cholesterol, and triglycerides used to be measured in the fasting state after 12 to 14 hours since the last meal. New guidelines suggest that lipid measurement could be done in a nonfasting state for the purpose of risk assessment and screening, but fasting measurements should be taken while assessing the efficacy of treatment, especially in patients with elevated triglyceride levels.

Low-density lipoprotein levels are usually calculated using the Friedewald formula:

LDL-C = TC – HDL-C – (TG/5 [mg/dL] or TG/2.2 [mmol/L])

Where: LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglyceride.

The calculations are unreliable in patients with a triglyceride level >4.6 mmol/L (400 mg/dL).

We would love to hear from you

Comments, mistakes, suggestions?


Industry Partners

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.